From an investor’s and product user’s perspective, ROSINBOMB, Inc. ROSN is too good to ignore. For the former, that sentiment results from its microcap share price not getting justice from an appraising process failing to consider its intrinsic and inherent strengths and the revenue-generating potentials attached to them. In ROSN’s case, at roughly $0.02 a share, its stock price is neglecting its leadership position in the CBD and organics extraction sector, its game-changing equipment and technology, and its ability to provide commercial-grade extraction equipment at a fraction of the cost of competing brands and as important, a fraction of their size that operates with simple plug-and-play capability.
It’s not as though ROSN is entirely under the radar, however. Investors have sent prices higher by over 233% YTD at their high. While they’ve returned some of that, ROSN shares are still over 111% higher than where they started the year. With volume getting more robust to support each leg higher, consolidating at the $0.02 level may not be such a bad thing. In fact, a rest may be just what ROSN needs to refuel technically to attack its 52-week high of $0.11, 450% higher than its current price. And with ROSN better positioned today than ever to accelerate penetrating lucrative markets that can deliver significantly higher revenues, that surge could happen faster than many expect.
…
Original Author Link click here to read complete story..
